CHICAGO--(BUSINESS WIRE)--March 22, 2006--CytoCore, Inc. (OTCBB: MCDG), with its recent product licenses, has assembled in four product components called the InPath System NG, a unique and complete system to address the various aspects of the traditional Pap test : the e2 Collector, the CVX/GCI Assay, the AIPS automated microscopy platform, and a new Drug Delivery System. Each product is an enhancement or upgrade to the current methods being used with the Pap test today.
